文献速递血液净化与透析

伴与不伴血流限制的步行训练在维持性血液透析患者中的随机对照试验

Randomized Controlled Trial of Walking Training with and without Blood Flow Restriction in Patients Treated with Maintenance Hemodialysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-04-04

该随机对照试验纳入苏州两个透析单位的57例维持性血液透析患者,随机分为对照组、步行训练组和步行训练联合血流限制组。8周干预后,两训练组在步行能力和生理功能方面均较对照组改善更明显,且联合组在16周时步行能力改善优于单纯步行训练组。

要点

  • 血流限制步行训练较常规护理在步行能力方面改善更明显。
  • 低强度、简单的步行干预可能成为血液透析患者的有效补充干预。
  • 8周干预后两训练组步行能力、生理功能和健康相关生活质量均改善。

核心结论

  • 8周干预后,步行训练联合血流限制和单纯步行训练均改善了维持性血液透析患者的步行能力、生理功能和健康相关生活质量。
  • 步行训练联合血流限制在血液透析人群中的长期获益需进一步研究。

研究设计与样本

  • 随机对照试验,于2024年2月至6月从中国苏州两个透析单位招募维持性血液透析患者。
  • 采用区组随机化将患者随机等额分配至对照组(n=19)、步行训练联合血流限制组(n=19)和步行训练组(n=19),共57例,平均年龄54岁(SD=10)。
  • 对照组接受常规护理;步行训练组接受8周低至中等强度步行干预;步行训练联合血流限制组接受与步行训练组相同的干预,并在步行训练期间施加40%–50%肢体闭塞压。
  • 在基线、8周和16周评估步行能力(主要结局)、生理功能、健康相关生活质量、焦虑和抑郁。

主要发现

  • 从基线至8周,步行训练联合血流限制组步行能力改善较对照组高48.48 m(95%CI 28.81至68.16 m)。
  • 从基线至8周,步行训练组步行能力改善较对照组高31.70 m(95%CI 9.29至54.11 m)。
  • 在16周时,步行训练联合血流限制组步行能力改善较步行训练组高34.63 m(95%CI 8.90至60.36 m)。
  • 步行训练联合血流限制组和步行训练组在生理功能及健康相关生活质量疾病特异性领域方面的改善均较对照组更明显。

局限性

  • 步行训练联合血流限制在血液透析人群中的长期获益需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: We compared the effectiveness of walking training with and without blood flow restriction on walking capacity in hemodialysis patients. Blood flow restriction walking resulted in greater improvements in walking capacity than usual care in hemodialysis patients. The low-intensity, simple walking-based intervention may be an effective complementary intervention for patients treated with hemodialysis. BACKGROUND: The decline in walking capacity among patients undergoing maintenance hemodialysis can worsen physical function, leading to impaired health-related quality of life (HRQOL). This randomized controlled trial compared the effectiveness of walking training with blood flow restriction (WT-BFR) and walking training (WT) versus usual care controls on walking capacity among hemodialysis patients. METHODS: Patients treated with maintenance hemodialysis were recruited from two dialysis units in Suzhou, China, between February and June 2024 and were randomly allocated into three groups using block randomization. The control group (CG) received usual care. The WT group received 8 weeks of low-to-moderate intensity walking intervention. The WT-BFR group received the same intervention as the WT group, with the addition of 40%–50% limb occlusion pressure applied during walking sessions. Walking capacity (primary outcome), physical function, HRQOL, anxiety, and depression were assessed at baseline, 8, and 16 weeks. RESULTS: Fifty-seven eligible patients with a mean age of 54 years (SD=10) were recruited. They were randomly allocated equally into the CG (n=19), WT-BFR group (n=19), and WT group (n=19). From baseline to 8 weeks, the improvements in walking capacity were greater in the WT-BFR (mean differences and 95% confidence interval, 48.48, 28.81 to 68.16 m) and WT (31.70, 9.29 to 54.11 m) groups compared with the CG. At 16 weeks, the WT-BFR group also demonstrated a greater improvement in walking capacity than the WT group (34.63, 8.90 to 60.36 m). Similarly, the WT-BFR and WT groups showed greater improvements in physical function and disease-specific domains of HRQOL, compared with the CG. CONCLUSIONS: After an 8-week intervention, both WT-BFR and WT improved walking capacity, physical function, and HRQOL in maintenance hemodialysis patients. However, the prolonged benefits of WT-BFR in the hemodialysis population require further investigation. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER:: Chinese Clinical Trial Register registration number: ChiCTR2400080779.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Hu H, Jiang X, Huang Y, et al. Randomized Controlled Trial of Walking Training with and without Blood Flow Restriction in Patients Treated with Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2025. PMID: 40344675. doi:10.2215/CJN.0000000701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。